To date, the most reported metastatic prostate cancer mouse models employ the PC3 cells or variants of these cells, including PC3-PIP, a cell line engineered to express PSMA, and PC3M a variant with higher incidence of metastases 23, 25, 27. This evidence concerns the gene FOLH1 and prostate carcinoma.